Thyrocare Technologies Limited (THYROCARE.BO)

INR 709.0

(0.19%)

EBITDA Summary of Thyrocare Technologies Limited

Thyrocare Technologies Limited's latest annual EBITDA in 2023 was 1.48 Billion INR , up 10.96% from previous year.
Thyrocare Technologies Limited's latest quarterly EBITDA in 2024 Q2 was 506.1 Million INR , up 9.4% from previous quarter.
Thyrocare Technologies Limited reported an annual EBITDA of 1.3 Billion INR in 2022, down -47.79% from previous year.
Thyrocare Technologies Limited reported an annual EBITDA of 2.64 Billion INR in 2021, up 36.26% from previous year.
Thyrocare Technologies Limited reported a quarterly EBITDA of 426.4 Million INR for 2024 Q1, up 24.02% from previous quarter.
Thyrocare Technologies Limited reported a quarterly EBITDA of 354.1 Million INR for 2023 Q1, up 54.56% from previous quarter.

Annual EBITDA Chart of Thyrocare Technologies Limited (2023 - 2012)

Historical Annual EBITDA of Thyrocare Technologies Limited (2023 - 2012)

Year	EBITDA	EBITDA Growth
2023	1.48 Billion INR	10.96%
2022	1.3 Billion INR	-47.79%
2021	2.64 Billion INR	36.26%
2020	1.83 Billion INR	2.8%
2019	1.73 Billion INR	6.08%
2018	1.64 Billion INR	4.39%
2017	1.65 Billion INR	21.68%
2016	999.2 Million INR	35.21%
2015	940.49 Million INR	24.95%
2014	743.99 Million INR	7.93%
2013	754.17 Million INR	8.62%
2012	812.86 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	506.1 Million INR	9.4%
2024 Q1	426.4 Million INR	24.02%
2023 Q1	354.1 Million INR	54.56%
2023 Q4	338.1 Million INR	-1.86%
2023 FY	- INR	10.96%
2023 Q3	344.5 Million INR	-13.98%
2023 Q2	400.5 Million INR	13.1%
2022 Q4	229.1 Million INR	-24.76%
2022 Q1	371.8 Million INR	-7.65%
2022 FY	- INR	-47.79%
2022 Q3	304.5 Million INR	-8.56%
2022 Q2	333 Million INR	-10.44%
2021 Q2	1.04 Billion INR	28.06%
2021 Q3	380 Million INR	-63.56%
2021 FY	- INR	36.26%
2021 Q4	402.6 Million INR	5.95%
2021 Q1	814.4 Million INR	78.56%
2020 Q2	668.4 Million INR	609.55%
2020 FY	- INR	2.8%
2020 Q4	456.1 Million INR	-12.72%
2020 Q1	94.2 Million INR	-66.58%
2020 Q3	522.6 Million INR	-21.81%
2019 Q1	481.5 Million INR	54.08%
2019 Q2	548.9 Million INR	14.0%
2019 Q3	447.1 Million INR	-18.55%
2019 Q4	281.9 Million INR	-36.95%
2019 FY	- INR	6.08%
2018 Q2	458.8 Million INR	5.67%
2018 FY	- INR	4.39%
2018 Q4	312.5 Million INR	-19.93%
2018 Q3	390.3 Million INR	-14.93%
2018 Q1	434.2 Million INR	-9.72%
2017 Q4	480.93 Million INR	23.16%
2017 Q2	393.8 Million INR	-4.39%
2017 Q3	390.5 Million INR	-0.84%
2017 Q1	411.9 Million INR	21.96%
2017 FY	- INR	21.68%
2016 Q1	300.22 Million INR	31.05%
2016 FY	- INR	35.21%
2016 Q2	499.72 Million INR	66.45%
2016 Q3	370.57 Million INR	-25.84%
2016 Q4	337.73 Million INR	-8.86%
2015 Q1	212.08 Million INR	0.0%
2015 Q2	288.99 Million INR	36.26%
2015 Q4	229.09 Million INR	-0.75%
2015 Q3	230.83 Million INR	-20.13%
2015 FY	- INR	24.95%
2014 FY	- INR	7.93%
2013 FY	- INR	8.62%
2012 FY	- INR	0.0%

Peer EBITDA Comparison of Thyrocare Technologies Limited

Name	EBITDA	EBITDA Difference
Krsnaa Diagnostics Limited	1.61 Billion INR	8.018%
Dr. Lal PathLabs Limited	6.78 Billion INR	78.157%
Metropolis Healthcare Limited	2.96 Billion INR	50.123%
Vijaya Diagnostic Centre Limited	2.2 Billion INR	32.942%
Vimta Labs Limited	906.39 Million INR	-63.429%